de la Fuente honored for AI research

Source Domain: www.asbmb.org

César de la Fuente has been chosen as a 2026 awardee for the University of Pennsylvania’s Discovering the Future of AI program, which supports research in artificial intelligence aimed at addressing critical health challenges like antimicrobial resistance.
The award funds his project, ApexMol, an advanced AI model designed to develop innovative biomolecules by utilizing 3D structures.
De la Fuente’s lab focuses on leveraging AI and machine learning to expedite advancements in biology and medicine, particularly in the design of peptides and antibiotics.
His team has made notable contributions, including the successful design of a computer-made antibiotic that showed efficacy in animal trials and pioneering the field of AI-driven antibiotic discovery.
De la Fuente has received multiple prestigious awards for his contributions to biomedical research, notably the XXXI Rafael Hervada Prize for his AI algorithms that identify antibiotics rapidly.
His achievements highlight the potential of AI to discover entirely new molecules, including those from ancient species, to tackle contemporary infectious diseases.

You may have missed